about
The role of adenosinergic pathway in human autoimmune diseasesOxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus ErythematosusIntestinal microbiota link lymphopenia to murine autoimmunity via PD-1+CXCR5-/dim B-helper T cell inductionPathways leading to an immunological disease: systemic lupus erythematosus.Infection in systemic lupus erythematosus, similarities, and differences with lupus flare.Glucose Oxidation Is Critical for CD4+ T Cell Activation in a Mouse Model of Systemic Lupus Erythematosus.Expression of TLR-7, MyD88, NF-kB, and INF-α in B Lymphocytes of Mayan Women with Systemic Lupus Erythematosus in MexicoFunction of Treg Cells Decreased in Patients With Systemic Lupus Erythematosus Due To the Effect of ProlactinThe cAMP response element modulator (CREM) regulates TH2 mediated inflammationSeveral Critical Cell Types, Tissues, and Pathways Are Implicated in Genome-Wide Association Studies for Systemic Lupus Erythematosus.Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway.The Lupus Susceptibility Gene Pbx1 Regulates the Balance between Follicular Helper T Cell and Regulatory T Cell Differentiation.Egr2 and Egr3 in regulatory T cells cooperatively control systemic autoimmunity through Ltbp3-mediated TGF-β3 production.Effects of N-acetyl-seryl-asparyl-lysyl-proline on blood pressure, renal damage, and mortality in systemic lupus erythematosusElevated expression of TIGIT on CD3+CD4+ T cells correlates with disease activity in systemic lupus erythematosus.Control of tissue-localized immune responses by human regulatory T cells.Stabilizing human regulatory T cells for tolerance inducing immunotherapy.Empowering Regulatory T Cells in Autoimmunity.T cells in Systemic Lupus Erythematosus.Low-Dose IL-2 in the Treatment of Lupus.Topics on vitamin D in systemic lupus erythematosus: analysis of evidence and critical literature review.Association between rs2294020 in X-linked CCDC22 and susceptibility to autoimmune diseases with focus on systemic lupus erythematosus.Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective.Short-term cytokine stimulation reveals regulatory T-cells with down-regulated Foxp3 expression in human peripheral blood.Maternal-Fetal rejection reactions are unconstrained in preeclamptic women.Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression.Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy.The PBX1 lupus susceptibility gene regulates CD44 expression.Elevated Regulatory T Cell Levels in Glaucoma Patients in Comparison to Healthy Controls.Targeting Regulatory T Cells to Treat Patients With Systemic Lupus Erythematosus.Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abataceptSerum Midkine Levels in Systemic Lupus Erythematosus
P2860
Q28069199-04B01C4B-5DD0-4174-9613-E17753BD7B1DQ28071300-0743DEA6-1124-4248-9F18-2D858CA1A8C7Q33604206-3C3D8364-BECF-47A8-A0B9-A563E95ED2B8Q33620555-D8893030-9518-40EC-B679-932035D31926Q33690722-AF29D0C1-75A7-4D61-AF81-ED57DBC9A4C6Q36387092-EDAB38DD-74CC-4DE3-9610-9FA0A162B2A3Q36527339-0218CFEE-4169-4C0D-B72B-7C56692A4F06Q36566751-EA56D477-5D02-48FE-AFF9-624491131816Q36629360-388BCB3A-3E4A-418A-A151-44DBF97CA71BQ36958117-7299DCC1-48E9-462A-A9A9-17172A421C8EQ37062514-1C95D5A1-107B-4DAE-9E3C-C59B43D430E5Q37072108-A6659713-8CF1-4D01-9A66-4F69F23FCAEFQ37514840-72A9A4A0-4650-4D06-AAAC-9CD249460285Q37609039-6BB9F988-1478-40D1-B425-1209F3C67D13Q37673346-F725E86C-A099-45F2-82BB-357A65A12BBBQ38265955-BECD6CED-5AE9-406B-82CA-7604A851E136Q38644779-865366C8-AE8A-4DB5-A6C7-B1EB50589E6DQ38909420-6BF63733-2492-4E4E-9C4E-E9B7A86BB04FQ38956350-3BA0958F-2CA7-403D-A404-446CE45C60C9Q38979253-F4E2C394-DC11-4F3F-94CD-38081A54CD04Q39147436-67D0978E-E67F-4AF5-B6F0-4862F93E3274Q39153182-7644F222-949C-4561-B2EE-547B9759BA3EQ39379152-412F79EF-E966-49BA-A18A-017E4474B31CQ41918204-6A41B399-9440-416B-B982-67125D59AF02Q46212939-23797384-FD70-4783-8C1B-7C84A6714FDBQ46215374-FCA2D9CE-30B6-4709-B163-0E315FE8A14FQ50111348-15F89116-D57F-495E-A72D-E5B89CC4DB1BQ50594269-A36BD3C2-66B7-4626-8AB6-CAB9D29BEA7DQ51410147-EDB5B60C-C8C2-41D1-8053-522F67F4234AQ55096330-63C87CF5-5128-4785-8EF1-D3D350A70753Q56890042-9A2256A8-7946-40B6-8FC3-8E0E097759E9Q58780764-04760DAD-B23E-4124-8F06-3753DF5519C7
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Regulatory T cells in systemic lupus erythematosus.
@en
type
label
Regulatory T cells in systemic lupus erythematosus.
@en
prefLabel
Regulatory T cells in systemic lupus erythematosus.
@en
P2860
P356
P1476
Regulatory T cells in systemic lupus erythematosus.
@en
P2093
Klaus Tenbrock
P2860
P304
P356
10.1002/EJI.201344280
P407
P577
2014-12-15T00:00:00Z